International Monetary Fund boss Christine Lagarde is being investigated by French prosecutors regarding a rare and minor charge of negligence in the use of public funds
The bidder's chief executive said he won't take no for an answer, and Dollar General's quarterly results show why
The law says campaigns and interest groups can’t coordinate, but that doesn’t stop them
A few years ago, big media companies were filing copyright lawsuits against YouTube. Now they’re buying in
There is increasing government and market scrutiny on for-profit schools, whose business model depends on enrollment
Chermayeff & Geismar has designed some of the most memorable corporate identities. But you may not have heard of them
At 56, the Purple One is fantastic in concert, but he hasn't made a really good album in years
Expenses surrounding cover-ups, legal counsel and support services can reach into the millions when sexual abuse scandals roil campuses, and insurance companies are obliging with new policies.
The St. Louis suburb's businesses face enormous challenges
Founders: Jeff Stein, John Finn, and John Schmid
VC Investment over the last four quarters: $35.16 million
Founded in 2004, the 35-employee biopharmaceutical company is working to develop antibacterial drugs to treat infections caused by resistant bacteria. Besides the VC investment, Stein says Trius has raised $32 million in government grants and contracts. As far as his perspective on the impact of the recession on his company, which expects less than $1 million in revenues in 2008, Stein says it will make the fundraising environment more challenging and may impact the partner environment as well.
Key to startup success: "Recruit top-tier executives. Focus on advancing your most valuable asset and seek alternative financing for earlier-stage programs."